VHCP Management’s Avadel Pharmaceuticals AVDL Stock Holding History

VHCP Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.2M	Hold	500,000	–	–	5.59%	5
2016 Q3	$6.2M	Hold	500,000	–	–	6.1%	4
2016 Q2	$5.37M	Hold	500,000	–	–	5.57%	4
2016 Q1	$5.52M	Hold	500,000	–	–	4.79%	7
2015 Q4	$6.11M	Hold	500,000	–	–	3.69%	8
2015 Q3	$8.15M	Hold	500,000	–	–	2.09%	13
2015 Q2	$10.6M	Hold	500,000	–	–	2.99%	11
2015 Q1	$8.99M	Hold	500,000	–	–	2.07%	12
2014 Q4	$8.56M	Hold	500,000	–	–	2.36%	12
2014 Q3	$7.16M	Hold	500,000	–	–	3.22%	10
2014 Q2	$7.5M	Hold	500,000	–	–	4.01%	9
2014 Q1	$6.7M	Buy	+500,000	New	+$5.36M	3.48%	10

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

VHCP Management's AVDL Position: Q4 2016 in Review

VHCP Management held its Avadel Pharmaceuticals (AVDL) position steady in Q4 2016 at 500,000 shares worth $5.2M. The position accounts for 5.59% of the portfolio, ranked #5.

VHCP Management first reported a position in AVDL in Q1 2014 and has held it in 12 quarters since. The position peaked at $10.6M in Q2 2015. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

VHCP Management held 500,000 shares of Avadel Pharmaceuticals worth $5.2M as of Q4 2016.
VHCP Management left its Avadel Pharmaceuticals share count unchanged in Q4 2016.
Avadel Pharmaceuticals made up 5.59% of VHCP Management's portfolio in Q4 2016, its #5 holding.
VHCP Management first reported a position in Avadel Pharmaceuticals in Q1 2014 and has held it in 12 quarters since.
VHCP Management's Avadel Pharmaceuticals position peaked at $10.6M in Q2 2015.
76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on VHCP Management's 13F filing for Q4 2016, filed 13 Feb 2017.